vs

Side-by-side financial comparison of ALUMIS INC. (ALMS) and Anterix Inc. (ATEX). Click either name above to swap in a different company.

ALUMIS INC. is the larger business by last-quarter revenue ($2.7M vs $1.6M, roughly 1.7× Anterix Inc.). ALUMIS INC. runs the higher net margin — 2225.1% vs -419.6%, a 2644.7% gap on every dollar of revenue. Anterix Inc. produced more free cash flow last quarter ($-8.3M vs $-107.0M).

ALUMIS INC. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for patients suffering from autoimmune and inflammatory disorders. It advances multiple product candidates through clinical trials, aiming to address unmet medical needs for patient populations across global markets.

Anterix Inc. is a U.S.-headquartered wireless communications company that owns licensed 900 MHz spectrum assets, providing secure, dedicated private broadband network solutions for critical infrastructure operators including electric utilities, public safety agencies, and transportation providers. Its primary market is North America, supporting clients requiring highly reliable connectivity for mission-critical operations.

ALMS vs ATEX — Head-to-Head

Bigger by revenue
ALMS
ALMS
1.7× larger
ALMS
$2.7M
$1.6M
ATEX
Higher net margin
ALMS
ALMS
2644.7% more per $
ALMS
2225.1%
-419.6%
ATEX
More free cash flow
ATEX
ATEX
$98.7M more FCF
ATEX
$-8.3M
$-107.0M
ALMS

Income Statement — Q2 FY2025 vs Q3 FY2026

Metric
ALMS
ALMS
ATEX
ATEX
Revenue
$2.7M
$1.6M
Net Profit
$59.3M
$-6.6M
Gross Margin
Operating Margin
-5271.5%
-576.0%
Net Margin
2225.1%
-419.6%
Revenue YoY
0.4%
Net Profit YoY
205.0%
-185.6%
EPS (diluted)
$0.77
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALMS
ALMS
ATEX
ATEX
Q4 25
$1.6M
Q3 25
$1.6M
Q2 25
$2.7M
$1.4M
Q1 25
$17.4M
$1.4M
Q4 24
$1.6M
Q3 24
$1.6M
Q2 24
$1.5M
Q1 24
$1.3M
Net Profit
ALMS
ALMS
ATEX
ATEX
Q4 25
$-6.6M
Q3 25
$53.5M
Q2 25
$59.3M
$25.2M
Q1 25
$-99.0M
$9.2M
Q4 24
$7.7M
Q3 24
$-12.8M
Q2 24
$-15.5M
Q1 24
$-9.4M
Operating Margin
ALMS
ALMS
ATEX
ATEX
Q4 25
-576.0%
Q3 25
Q2 25
-5271.5%
Q1 25
-583.9%
Q4 24
Q3 24
-846.6%
Q2 24
-984.4%
Q1 24
-834.2%
Net Margin
ALMS
ALMS
ATEX
ATEX
Q4 25
-419.6%
Q3 25
3449.5%
Q2 25
2225.1%
1775.7%
Q1 25
-569.1%
662.9%
Q4 24
492.3%
Q3 24
-823.1%
Q2 24
-1018.0%
Q1 24
-746.9%
EPS (diluted)
ALMS
ALMS
ATEX
ATEX
Q4 25
$-0.35
Q3 25
$2.86
Q2 25
$0.77
$1.35
Q1 25
$-1.82
$0.51
Q4 24
$0.41
Q3 24
$-0.69
Q2 24
$-0.84
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALMS
ALMS
ATEX
ATEX
Cash + ST InvestmentsLiquidity on hand
$486.3M
$29.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$485.3M
$236.0M
Total Assets
$610.9M
$417.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALMS
ALMS
ATEX
ATEX
Q4 25
$29.5M
Q3 25
$39.1M
Q2 25
$486.3M
$41.4M
Q1 25
$208.7M
$47.4M
Q4 24
$28.8M
Q3 24
$43.1M
Q2 24
$51.7M
Q1 24
$60.6M
Stockholders' Equity
ALMS
ALMS
ATEX
ATEX
Q4 25
$236.0M
Q3 25
$240.3M
Q2 25
$485.3M
$184.8M
Q1 25
$168.3M
$156.6M
Q4 24
$144.7M
Q3 24
$139.1M
Q2 24
$148.8M
Q1 24
$161.0M
Total Assets
ALMS
ALMS
ATEX
ATEX
Q4 25
$417.0M
Q3 25
$420.4M
Q2 25
$610.9M
$359.6M
Q1 25
$261.3M
$333.1M
Q4 24
$326.7M
Q3 24
$317.2M
Q2 24
$321.1M
Q1 24
$324.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALMS
ALMS
ATEX
ATEX
Operating Cash FlowLast quarter
$-106.4M
$-8.3M
Free Cash FlowOCF − Capex
$-107.0M
$-8.3M
FCF MarginFCF / Revenue
-4012.3%
-526.4%
Capex IntensityCapex / Revenue
23.1%
0.6%
Cash ConversionOCF / Net Profit
-1.79×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALMS
ALMS
ATEX
ATEX
Q4 25
$-8.3M
Q3 25
$1.4M
Q2 25
$-106.4M
$-3.1M
Q1 25
$-80.4M
$-16.6M
Q4 24
$-7.7M
Q3 24
$-2.6M
Q2 24
$-2.4M
Q1 24
$6.1M
Free Cash Flow
ALMS
ALMS
ATEX
ATEX
Q4 25
$-8.3M
Q3 25
Q2 25
$-107.0M
Q1 25
$-80.4M
$-16.6M
Q4 24
Q3 24
$-2.7M
Q2 24
Q1 24
$6.1M
FCF Margin
ALMS
ALMS
ATEX
ATEX
Q4 25
-526.4%
Q3 25
Q2 25
-4012.3%
Q1 25
-462.3%
-1195.2%
Q4 24
Q3 24
-173.4%
Q2 24
Q1 24
484.1%
Capex Intensity
ALMS
ALMS
ATEX
ATEX
Q4 25
0.6%
Q3 25
Q2 25
23.1%
Q1 25
0.2%
3.3%
Q4 24
0.0%
Q3 24
2.6%
Q2 24
0.0%
Q1 24
3.2%
Cash Conversion
ALMS
ALMS
ATEX
ATEX
Q4 25
Q3 25
0.03×
Q2 25
-1.79×
-0.12×
Q1 25
-1.80×
Q4 24
-1.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons